Metraipolis › archive › dc_bef26295e9ef

Metabolic factors influencing the efficacy of recombinant human growth hormone therapy in children with short stature — Europe PMC PMID:41282298

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41282298
DOI
10.3389/fendo.2025.1691509
License (as archived)
solo-consultazione
Archived
2026-11-08T18:27:18.148Z
SHA-256 of the archived text
94b90627bb6d353fcadbcb891070b63339e74e5e7b5a1e45762ce136c1057523
Stable URL of this page
https://metraipolis.com/documento/dc_bef26295e9ef

How to cite

Metabolic factors influencing the efficacy of recombinant human growth hormone therapy in children with short stature — Europe PMC PMID:41282298 — Europe PMC (en), https://europepmc.org/article/MED/41282298 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bef26295e9ef (Metraipolis archive dc_bef26295e9ef, sha256 94b90627bb6d353fcadbcb891070b63339e74e5e7b5a1e45762ce136c1057523)
BibTeX
@misc{dcbef26295e9ef,
  title = {Metabolic factors influencing the efficacy of recombinant human growth hormone therapy in children with short stature — Europe PMC PMID:41282298},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41282298},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bef26295e9ef; sha256 94b90627bb6d353fcadbcb891070b63339e74e5e7b5a1e45762ce136c1057523},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41282298. Agents can read the archived copy with the MCP tool read_document.